Namenda
- Product NDC
- 67046-489
- 11-digit product format
- 670460489
- Labeler code
- 67046
- Product ID
- 67046-489_bc6e059d-1951-4fa3-b904-230d4165724d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- memantine hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Contract Pharmacy Services-PA
- Application
- NDA021487
- Marketing category
- NDA
- Marketing start
- 2010-03-19
- Marketing end
- 0000-00-00
- Substance
- MEMANTINE HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- NMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 67046-489 | I | Inactivated by FDA | 2026-07-31 | ||
| excluded package | package | 67046-489 | 67046-489-60 | I | Inactivated by FDA | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021487-001 | NAMENDA | MEMANTINE HYDROCHLORIDE | 5MG | TABLET / ORAL | RLD | 2003-10-16 | |
| N021487-002 | NAMENDA | MEMANTINE HYDROCHLORIDE | 10MG | TABLET / ORAL | RLD | 2003-10-16 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N021487-001 | NAMENDA | 5MG | TABLET / ORAL | RLD | 2003-10-16 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N021487-002 | NAMENDA | 10MG | TABLET / ORAL | RLD | 2003-10-16 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| memantine hydrochloride | MEMANTINE HYDROCHLORIDE | Cardinal Health 107, LLC | e5754973-e73b-4a25-abb4-80f91880f018 | 2026-06-05 | Warnings, Adverse reactions | 021487 NDA021487 |
| memantine hydrochloride | MEMANTINE HYDROCHLORIDE | Actavis Pharma, Inc. | 72973b46-f307-4a9e-8fb1-ad2cbccfd736 | 2018-11-01 | Warnings, Adverse reactions | 021487 NDA021487 |
| memantine hydrochloride | MEMANTINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | c8f5c20b-4573-44c5-89fc-4da11b2e1fe1 | 2017-11-30 | Warnings, Adverse reactions | 021487 NDA021487 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 94db636e-a074-45fd-8e8d-331920a99436 | Product name | 4 | 20250103 |
| 941773f8-a40e-0684-da08-ff9a143e6368 | Product name | 7 | 20231219 |
| 5b597f00-4538-4686-aa4e-3c60ed3788c8 | Product name | 2 | 20210511 |
| 1836e79a-a4d1-4087-2f2e-f878e8a1fef2 | Product name | 9 | 20151209 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67046-489-60 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-bc58-621f-e053-dbdaa90a74ad | bc6e059d-1951-4fa3-b904-230d4165724d |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67046-489-60 | Namenda | 60 in 1 BLISTER PACK | TABLET | 60 | 1 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 996561 | memantine HCl 10 MG Oral Tablet | PSN | bc6e059d-1951-4fa3-b904-230d4165724d | 1 |
| 996563 | Namenda 10 MG Oral Tablet | PSN | bc6e059d-1951-4fa3-b904-230d4165724d | 1 |
| 996563 | memantine hydrochloride 10 MG Oral Tablet [Namenda] | SBD | bc6e059d-1951-4fa3-b904-230d4165724d | 1 |
| 996561 | memantine hydrochloride 10 MG Oral Tablet | SCD | bc6e059d-1951-4fa3-b904-230d4165724d | 1 |
| 996563 | Namenda 10 MG Oral Tablet | SY | bc6e059d-1951-4fa3-b904-230d4165724d | 1 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 67046-489-60 | 67046048960 | 60 in 1 BLISTER PACK | Historical |